Gestational trophoblastic neoplasia (GTN)
What is Gestational trophoblastic neoplasia (GTN)?
Gestational trophoblastic neoplasia is a rare group of tumors that grow in the uterus after pregnancy. These tumors develop from cells that would normally form the placenta. GTN includes invasive mole, choriocarcinoma, and placental site trophoblastic tumor. All types grow from tissue that was part of a pregnancy.
GTN most often develops after a molar pregnancy. A molar pregnancy happens when abnormal tissue grows instead of a healthy embryo. Sometimes GTN appears after a normal pregnancy, miscarriage, or ectopic pregnancy. The tumor cells produce high levels of human chorionic gonadotropin, also called hCG. This hormone can be measured through blood testing.
GTN is highly treatable when caught early. Most women who receive treatment go on to have successful future pregnancies. Regular monitoring with hCG blood tests helps doctors detect GTN quickly and track how well treatment is working.
Symptoms
- Vaginal bleeding after pregnancy, miscarriage, or molar pregnancy removal
- Persistently positive pregnancy tests weeks or months after pregnancy ends
- Pelvic pain or pressure
- Enlarged uterus that does not return to normal size
- Cough or chest pain if cancer spreads to the lungs
- Headaches or neurological symptoms if cancer spreads to the brain
- Abdominal swelling or discomfort
- Severe nausea or vomiting
Some women have no early symptoms. GTN may be detected only through routine hCG monitoring after molar pregnancy or other pregnancy complications.
Concerned about Gestational trophoblastic neoplasia (GTN)? Check your levels.
Screen for 1,200+ health conditions
Causes and risk factors
GTN develops when placental tissue grows abnormally after pregnancy. The exact trigger is not fully understood. Most cases follow a molar pregnancy, where abnormal cells form instead of a healthy embryo. About 15 to 20 percent of molar pregnancies progress to GTN. GTN can also appear after normal pregnancy, miscarriage, ectopic pregnancy, or abortion.
Risk factors include previous molar pregnancy, age under 20 or over 35 during pregnancy, history of miscarriage, and blood type A. Women of Asian, Native American, or Hispanic descent face slightly higher risk. Having one molar pregnancy raises the chance of having another. Good nutrition, especially adequate vitamin A and carotene intake, may lower risk.
How it's diagnosed
GTN is diagnosed through hCG blood testing and imaging studies. Doctors measure hCG levels regularly after molar pregnancy or other pregnancy complications. Rising or plateauing hCG levels indicate possible GTN. Normal hCG should drop steadily to zero after pregnancy ends. If levels stay elevated beyond 6 months or rise at any point, GTN is likely.
Rite Aid offers hCG testing to monitor levels after pregnancy complications. Regular blood tests help catch GTN early when it is most treatable. Your doctor may also order ultrasound, CT scans, or MRI to look for tumor growth. A biopsy is rarely needed because hCG levels and imaging usually provide clear diagnosis.
Treatment options
- Chemotherapy is the primary treatment and cures most cases
- Single drug regimens for low-risk disease, combination therapy for high-risk cases
- Surgery to remove the uterus if chemotherapy does not work
- Weekly hCG blood tests during treatment to track response
- Monthly monitoring for one year after hCG reaches zero
- Avoid pregnancy during treatment and for one year after completion
- Use reliable contraception during recovery period
- Nutritious diet to support healing and immune function
- Emotional support through counseling or support groups
Need testing for Gestational trophoblastic neoplasia (GTN)? Add it to your panel.
- Simple blood draw at your nearest lab
- Results in days, not weeks
- Share results with your doctor
Frequently asked questions
Gestational trophoblastic neoplasia is a rare group of tumors that develop in the uterus from placental tissue after pregnancy. These tumors grow from cells that would normally form the placenta during pregnancy. GTN includes invasive mole, choriocarcinoma, and placental site trophoblastic tumor. It most commonly follows molar pregnancy but can occur after any pregnancy event.
GTN is detected by measuring human chorionic gonadotropin levels in the blood. hCG normally drops to zero within weeks after pregnancy ends. If hCG levels stay elevated, rise, or plateau during monitoring, this suggests GTN. Regular blood testing after molar pregnancy or pregnancy complications allows early detection when treatment is most effective.
GTN develops when placental tissue continues to grow abnormally after pregnancy. The exact cause is unknown, but it most often follows molar pregnancy. About 15 to 20 percent of molar pregnancies progress to GTN. Risk factors include age under 20 or over 35, previous molar pregnancy, and certain ethnic backgrounds.
Early signs include vaginal bleeding after pregnancy ends and persistently positive pregnancy tests. Some women experience pelvic pain, an enlarged uterus that does not shrink, or severe nausea. Many women have no symptoms at all. GTN is often detected only through routine hCG monitoring after pregnancy complications.
Yes, GTN can spread beyond the uterus to the lungs, liver, brain, or other organs. When it spreads to the lungs, symptoms may include cough or chest pain. Brain involvement can cause headaches or neurological symptoms. Regular monitoring with blood tests and imaging helps detect spread early so treatment can begin quickly.
Yes, GTN is highly curable with chemotherapy. Cure rates exceed 90 percent even when cancer has spread. Early detection through hCG monitoring improves outcomes. Most women complete treatment successfully and can have healthy pregnancies in the future.
After molar pregnancy removal, hCG should be tested weekly until levels reach zero. Testing then continues monthly for 6 to 12 months to ensure levels stay at zero. If levels rise or plateau at any point, more frequent testing and evaluation for GTN are needed.
Yes, most women can have successful pregnancies after GTN treatment. However, you should avoid pregnancy during treatment and for one year after hCG reaches zero. This waiting period ensures the cancer is fully gone and reduces risk of recurrence. Use reliable birth control during this time.
Molar pregnancy is a non-cancerous growth where abnormal tissue forms instead of a healthy embryo. GTN is cancer that develops when placental tissue continues growing abnormally after pregnancy. About 15 to 20 percent of molar pregnancies progress to GTN. Regular hCG monitoring after molar pregnancy helps detect this progression early.
There is no proven way to prevent GTN, but good nutrition may reduce risk. Diets rich in vitamin A and carotene from colorful fruits and vegetables may be protective. If you have had one molar pregnancy, work closely with your doctor during future pregnancies. Early prenatal care and monitoring help detect any problems quickly.